{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:08:56Z","timestamp":1790039336164,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s13555-024-01154-8","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T17:02:29Z","timestamp":1714064549000},"page":"1337-1348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of Biologic Therapy on Key Cardiovascular Risk Parameters in a Psoriatic Cohort\u2014a Retrospective Review"],"prefix":"10.1007","volume":"14","author":[{"given":"Joseph","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serigne N.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara K.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9520-920X","authenticated-orcid":false,"given":"Annika","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"issue":"10","key":"1154_CR1","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/ijms18102211","volume":"18","author":"SC-S Hu","year":"2017","unstructured":"Hu SC-S, Lan C-CE. Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment. Int J Mol Sci. 2017;18(10):2211. https:\/\/doi.org\/10.3390\/ijms18102211.","journal-title":"Int J Mol Sci."},{"issue":"11","key":"1154_CR2","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/jamadermatol.2016.2907","volume":"152","author":"B Mansouri","year":"2016","unstructured":"Mansouri B, Kivelevitch D, Natarajan B, Joshi AA, Ryan C, Benjegerdes K, et al. Comparison of coronary artery calcium scores between patients with psoriasis and type 2 diabetes. JAMA Dermatol. 2016;152(11):1244\u201353. https:\/\/doi.org\/10.1001\/jamadermatol.2016.2907.","journal-title":"JAMA Dermatol"},{"issue":"8","key":"1154_CR3","doi-asserted-by":"publisher","first-page":"775 e1","DOI":"10.1016\/j.amjmed.2011.03.028","volume":"124","author":"NN Mehta","year":"2011","unstructured":"Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011;124(8):775 e1-776. https:\/\/doi.org\/10.1016\/j.amjmed.2011.03.028.","journal-title":"Am J Med"},{"issue":"10","key":"1154_CR4","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1038\/jid.2013.149","volume":"133","author":"EJ Samarasekera","year":"2013","unstructured":"Samarasekera EJ, Neilson JM, Warren RB, Parnham J, Smith CH. Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis. J Invest Dermatol. 2013;133(10):2340\u20136. https:\/\/doi.org\/10.1038\/jid.2013.149.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1154_CR5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bjd.15021","volume":"176","author":"DA Springate","year":"2017","unstructured":"Springate DA, Parisi R, Kontopantelis E, Reeves D, Griffiths CE, Ashcroft DM. Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol. 2017;176(3):650\u20138. https:\/\/doi.org\/10.1111\/bjd.15021.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1154_CR6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2195","volume":"10","author":"S Jindal","year":"2018","unstructured":"Jindal S, Jindal N. Psoriasis and cardiovascular diseases: a literature review to determine the causal relationship. Cureus. 2018;10(2): e2195. https:\/\/doi.org\/10.7759\/cureus.2195.","journal-title":"Cureus"},{"key":"1154_CR7","unstructured":"Arnett D, Blumenthal R, Albert M. et al. 2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines"},{"issue":"13","key":"1154_CR8","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","volume":"77","author":"MS Garshick","year":"2021","unstructured":"Garshick MS, Ward NL, Krueger JG, Berger JS. Cardiovascular risk in patients with\u00a0psoriasis: JACC review topic of the week. J Am Coll Cardiol. 2021;77(13):1670\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1154_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/cvr\/cvz009","volume":"115","author":"YA Elnabawi","year":"2019","unstructured":"Elnabawi YA, Dey AK, Goyal A, Groenendyk JW, Chung JH, Belur AD, et al. Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study. Cardiovasc Res. 2019;115(4):721\u20138. https:\/\/doi.org\/10.1093\/cvr\/cvz009.","journal-title":"Cardiovasc Res"},{"issue":"10","key":"1154_CR10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1001\/jamadermatol.2016.1984","volume":"152","author":"KF Hjuler","year":"2016","unstructured":"Hjuler KF, B\u00f8ttcher M, Vestergaard C, B\u00f8tker HE, Iversen L, Kragballe K. Association between changes in coronary artery disease progression and treatment with biologic agents for severe psoriasis. JAMA Dermatol. 2016;152(10):1114\u201321. https:\/\/doi.org\/10.1001\/jamadermatol.2016.1984.","journal-title":"JAMA Dermatol"},{"issue":"22","key":"1154_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.017417","volume":"9","author":"W Zhou","year":"2020","unstructured":"Zhou W, Abdelrahman KM, Dey AK, Reddy A, Uceda DE, Lateef SS, et al. Association among noncalcified coronary burden, fractional flow reserve, and myocardial injury in psoriasis. J Am Heart Assoc. 2020;9(22): e017417. https:\/\/doi.org\/10.1161\/JAHA.119.017417.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1154_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s13671-018-0210-4","volume":"7","author":"M Henning","year":"2018","unstructured":"Henning M, Tekin HG, Skov L, Egeberg A. Effects of biologic therapy on cardiovascular disease in psoriasis. Curr Dermatol Rep. 2018;7(1):37\u201342. https:\/\/doi.org\/10.1007\/s13671-018-0210-4.","journal-title":"Curr Dermatol Rep"},{"issue":"12","key":"1154_CR13","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1707914.","journal-title":"N Engl J Med"},{"issue":"14","key":"1154_CR14","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735\u201341. https:\/\/doi.org\/10.1001\/jama.296.14.1735.","journal-title":"JAMA"},{"issue":"2","key":"1154_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.113.000062","volume":"2","author":"EJ Armstrong","year":"2013","unstructured":"Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc. 2013;2(2): e000062. https:\/\/doi.org\/10.1161\/jaha.113.000062.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"1154_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1056\/NEJMe1709904","volume":"377","author":"RA Harrington","year":"2017","unstructured":"Harrington RA. Targeting inflammation in coronary artery disease. N Engl J Med. 2017;377(12):1197\u20138. https:\/\/doi.org\/10.1056\/NEJMe1709904.","journal-title":"N Engl J Med"},{"key":"1154_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01234","author":"AP Sajja","year":"2018","unstructured":"Sajja AP, Joshi AA, Teague HL, Dey AK, Mehta NN. Potential immunological links between psoriasis and cardiovascular disease. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.01234.","journal-title":"Front Immunol"},{"issue":"3","key":"1154_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/circulationaha.116.026859","volume":"136","author":"JB Lerman","year":"2017","unstructured":"Lerman JB, Joshi AA, Chaturvedi A, Aberra TM, Dey AK, Rodante JA, et al. Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study. Circulation. 2017;136(3):263\u201376. https:\/\/doi.org\/10.1161\/circulationaha.116.026859.","journal-title":"Circulation"},{"issue":"1","key":"1154_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s13555-019-00337-y","volume":"10","author":"RB Warren","year":"2020","unstructured":"Warren RB, See K, Burge R, Zhang Y, Brnabic A, Gallo G, et al. Rapid response of biologic treatments of moderate-to-severe plaque psoriasis: a comprehensive investigation using bayesian and frequentist network meta-analyses. Dermatol Therapy. 2020;10(1):73\u201386. https:\/\/doi.org\/10.1007\/s13555-019-00337-y.","journal-title":"Dermatol Therapy"},{"issue":"4","key":"1154_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","volume":"20","author":"WH Boehncke","year":"2011","unstructured":"Boehncke WH, Boehncke S, Tobin AM, Kirby B. The \u201cpsoriatic march\u201d: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol. 2011;20(4):303\u20137. https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01261.x.","journal-title":"Exp Dermatol"},{"issue":"9","key":"1154_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.120.011199","volume":"13","author":"H Choi","year":"2020","unstructured":"Choi H, Uceda DE, Dey AK, Abdelrahman KM, Aksentijevich M, Rodante JA, et al. Treatment of psoriasis with biologic therapy is associated with improvement of coronary artery plaque lipid-rich necrotic core: results from a prospective, observational study. Circ Cardiovasc Imaging. 2020;13(9): e011199. https:\/\/doi.org\/10.1161\/circimaging.120.011199.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"1154_CR22","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/circulationaha.106.171016","volume":"113","author":"P Poirier","year":"2006","unstructured":"Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American heart association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation. 2006;113(6):898\u2013918. https:\/\/doi.org\/10.1161\/circulationaha.106.171016.","journal-title":"Circulation"},{"key":"1154_CR23","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3389\/fimmu.2019.01807","volume":"10","author":"M Kunz","year":"2019","unstructured":"Kunz M, Simon JC, Saalbach A. Psoriasis: obesity and fatty acids. Front Immunol. 2019;10:1807. https:\/\/doi.org\/10.3389\/fimmu.2019.01807.","journal-title":"Front Immunol"},{"issue":"15","key":"1154_CR24","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/archinte.167.15.1670","volume":"167","author":"AR Setty","year":"2007","unstructured":"Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: nurses\u2019 health study II. Arch Intern Med. 2007;167(15):1670\u20135. https:\/\/doi.org\/10.1001\/archinte.167.15.1670.","journal-title":"Arch Intern Med"},{"issue":"12","key":"1154_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2012.26","volume":"2","author":"AW Armstrong","year":"2012","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes. 2012;2(12): e54. https:\/\/doi.org\/10.1038\/nutd.2012.26. (PMID:23208415;PMCID:PMC3542430).","journal-title":"Nutr Diabetes"},{"issue":"6","key":"1154_CR26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1517\/14712598.2014.900541","volume":"14","author":"N Al-Mutairi","year":"2014","unstructured":"Al-Mutairi N, Nour T. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opin Biol Ther. 2014;14(6):749\u201356. https:\/\/doi.org\/10.1517\/14712598.2014.900541. (Epub 2014 Mar 24 PMID: 24661040).","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"1154_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4103\/0019-5545.120531","volume":"55","author":"TS Sathyanarayana Rao","year":"2013","unstructured":"Sathyanarayana Rao TS, Basavaraj KH, Das K. Psychosomatic paradigms in psoriasis: psoriasis, stress and mental health. Indian J Psychiatry. 2013;55(4):313\u20135. https:\/\/doi.org\/10.4103\/0019-5545.120531.","journal-title":"Indian J Psychiatry"},{"issue":"2","key":"1154_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/jamadermatol.2014.2094","volume":"151","author":"J Takeshita","year":"2015","unstructured":"Takeshita J, Wang S, Shin DB, Mehta NN, Kimmel SE, Margolis DJ, et al. Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA Dermatol. 2015;151(2):161\u20139. https:\/\/doi.org\/10.1001\/jamadermatol.2014.2094.","journal-title":"JAMA Dermatol"},{"issue":"9623","key":"1154_CR29","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/s0140-6736(08)60655-8","volume":"371","author":"CM Lawes","year":"2008","unstructured":"Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet (London, England). 2008;371(9623):1513\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(08)60655-8.","journal-title":"Lancet (London, England)"},{"issue":"3","key":"1154_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","volume":"31","author":"AW Armstrong","year":"2013","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2013;31(3):433\u201342. https:\/\/doi.org\/10.1097\/HJH.0b013e32835bcce1.","journal-title":"J Hypertens"},{"key":"1154_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.12659\/msm.889197","volume":"19","author":"A Bacaksiz","year":"2013","unstructured":"Bacaksiz A, Erdogan E, Sonmez O, Sevgili E, Tasal A, Onsun N, et al. Ambulatory blood pressure monitoring can unmask hypertension in patients with psoriasis vulgaris. Med Sci Monit. 2013;19:501\u20139. https:\/\/doi.org\/10.12659\/msm.889197.","journal-title":"Med Sci Monit"},{"key":"1154_CR32","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.117.005729","author":"H Tomiyama","year":"2017","unstructured":"Tomiyama H, Shiina K, Matsumoto-Nakano C, Ninomiya T, Komatsu S, Kimura K, et al. The contribution of inflammation to the development of hypertension mediated by increased arterial stiffness. J Am Heart Assoc. 2017. https:\/\/doi.org\/10.1161\/jaha.117.005729.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1154_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.mehy.2004.06.017","volume":"64","author":"JJ Li","year":"2005","unstructured":"Li JJ, Fang CH, Hui RT. Is hypertension an inflammatory disease? Med Hypotheses. 2005;64(2):236\u201340. https:\/\/doi.org\/10.1016\/j.mehy.2004.06.017.","journal-title":"Med Hypotheses"},{"issue":"1","key":"1154_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13075-018-1597-9","volume":"20","author":"Z Yu","year":"2018","unstructured":"Yu Z, Kim SC, Vanni K, Huang J, Desai R, Murphy SN, et al. Association between inflammation and systolic blood pressure in RA compared to patients without RA. Arthritis Res Ther. 2018;20(1):107. https:\/\/doi.org\/10.1186\/s13075-018-1597-9.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"1154_CR35","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1001\/jama.1992.03480090061028","volume":"267","author":"PK Whelton","year":"1992","unstructured":"Whelton PK, Appel L, Charleston J, Dalcin AT, Ewart C, Fried L, et al. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the trials of hypertension prevention. Phase I Jama. 1992;267(9):1213\u201320. https:\/\/doi.org\/10.1001\/jama.1992.03480090061028.","journal-title":"Phase I Jama"},{"issue":"1","key":"1154_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pcad.2009.05.003","volume":"52","author":"C Perret-Guillaume","year":"2009","unstructured":"Perret-Guillaume C, Joly L, Benetos A. Heart rate as a risk factor for cardiovascular disease. Prog Cardiovasc Dis. 2009;52(1):6\u201310. https:\/\/doi.org\/10.1016\/j.pcad.2009.05.003.","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"1154_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1159\/000351884","volume":"22","author":"B Sarli","year":"2013","unstructured":"Sarli B, Dogan Y, Baktir AO, Saglam H, Arinc H, Kurtul S, et al. Heart rate recovery is impaired in patients with psoriasis. Med Princ Pract. 2013;22(6):567\u201370. https:\/\/doi.org\/10.1159\/000351884.","journal-title":"Med Princ Pract"},{"issue":"1","key":"1154_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.arcmed.2006.08.004","volume":"38","author":"L Markuszeski","year":"2007","unstructured":"Markuszeski L, Bissinger A, Janusz I, Narbutt J, Jedrzejowska AS, Zalewska A. Heart rate and arrhythmia in patients with psoriasis vulgaris. Arch Med Res. 2007;38(1):64\u20139. https:\/\/doi.org\/10.1016\/j.arcmed.2006.08.004.","journal-title":"Arch Med Res"},{"issue":"1","key":"1154_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jaad.2014.02.012","volume":"71","author":"M Debbaneh","year":"2014","unstructured":"Debbaneh M, Millsop JW, Bhatia BK, Koo J, Liao W. Diet and psoriasis, part I: impact of weight loss interventions. J Am Acad Dermatol. 2014;71(1):133\u201340. https:\/\/doi.org\/10.1016\/j.jaad.2014.02.012. (Epub 2014 Apr 4. PMID: 24709272; PMCID: PMC4065614).","journal-title":"J Am Acad Dermatol."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01154-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01154-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T13:27:10Z","timestamp":1716470830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01154-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01154-8","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interests for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was approved by the Ethics Committee at Westmead Hospital, NSW, Australia, reference number 2105\u201307, and was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}